rs746218707
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000057.4(BLM):āc.3163T>Cā(p.Cys1055Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 152,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C1055S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000057.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BLM | NM_000057.4 | c.3163T>C | p.Cys1055Arg | missense_variant | 16/22 | ENST00000355112.8 | NP_000048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BLM | ENST00000355112.8 | c.3163T>C | p.Cys1055Arg | missense_variant | 16/22 | 1 | NM_000057.4 | ENSP00000347232.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152168Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
Bloom syndrome Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 06, 2024 | Variant summary: BLM c.3163T>C (p.Cys1055Arg) results in a non-conservative amino acid change located in the ATP-dependent DNA helicase RecQ, zinc-binding domain (IPR032284) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 248860 control chromosomes. c.3163T>C has been reported in the literature in the presumed compound heterozygous state in at least 1 individual affected with Bloom Syndrome (example, German_2007). These data do not allow any conclusion about variant significance. At least 2 different variants affecting the same codon have been classified as likely pathogenic/pathogenic by our lab or other labs in ClinVar (c.3164G>C, p.Cys1055Ser; c.3163T>G p.Cys1055Gly), supporting the critical relevance of codon 1055 to BLM protein function. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported for this variant, p.Cys1055Arg. The following publication has been ascertained in the context of this evaluation (PMID: 17407155). ClinVar contains an entry for this variant (Variation ID: 549904). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 07, 2023 | - - |
Uncertain significance, flagged submission | clinical testing | Counsyl | Dec 24, 2017 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The p.C1055R variant (also known as c.3163T>C), located in coding exon 15 of the BLM gene, results from a T to C substitution at nucleotide position 3163. The cysteine at codon 1055 is replaced by arginine, an amino acid with highly dissimilar properties. This alteration has been identified in one patient with Bloom syndrome who also carried c.2098C>T (German J et al. Hum Mutat, 2007 Aug;28:743-53). Another alteration at the same codon, p.C1055S (c.3164G>C), has been reported in the literature in both a homozygous and compound heterozygous state in individuals with Bloom syndrome (Ellis NA et al. Cell, 1995 Nov;83:655-66; German J et al. Hum. Mutat., 2007 Aug;28:743-53; Montenegro MM et al. Mol Genet Genomic Med, 2020 04;8:e1133). Functional studies of p.C1055S have also demonstrated that this alteration causes reduced BLM protein expression and lacks detectable helicase and DNA-dependent ATPase activities, which are essential for wild-type interaction of BLM with tp53 in the DNA damage response pathway (Wang XW et al. J. Biol. Chem., 2001 Aug;276:32948-55; Neff NF et al. Mol. Biol. Cell, 1999 Mar;10:665-76). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at